SCHEMBL8973603

SCHEMBL8973603

O=C1CN(S(=O)(=O)c2ccc3cccc(Cl)c3c2)C(=O)N1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.45
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
SHMT2 P34897 1/20 0.42
HSD17B10 Q99714 1/20 0.42
MMP2 P08253 2/20 0.42
ALDH1A1 P00352 2/20 0.39
POLB P06746 2/20 0.39
MAPT P10636 2/20 0.39
HTR6 P50406 1/20 0.38
PKM P14618 1/20 0.37
CMA1 P23946 2/20 0.37
TP53 P04637 1/20 0.36
MCOLN3 Q8TDD5 2/20 0.36
TSHR P16473 1/20 0.36
GAA P10253 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8973561 0.90 HTR6 (0.47) TDP1MEN1KMT2ASHMT2HSD17B10
SCHEMBL8973411 0.81 PKM (0.52) MEN1KMT2AHSD17B10ALDH1A1POLB
SCHEMBL8973357 0.79 MEN1 (0.51) TDP1MEN1KMT2AHSD17B10MMP2
SCHEMBL10680095 0.77 HSD17B10 (0.42) TDP1MEN1KMT2ASHMT2HSD17B10
SCHEMBL10675527 0.76 KMT2A (0.54) MEN1KMT2AHSD17B10ALDH1A1POLB
SCHEMBL8973198 0.74 ALDH1A1 (0.42) TDP1MEN1KMT2ASHMT2HSD17B10
SCHEMBL8972857 0.74 MEN1 (0.40) MEN1KMT2AHSD17B10ALDH1A1POLB
SCHEMBL8799786 0.73 HDAC3 (0.37) TDP1MEN1KMT2AHSD17B10MMP2
SCHEMBL8799201 0.73 HDAC3 (0.37) TDP1MEN1KMT2AHSD17B10MMP2
SCHEMBL8973637 0.73 MMP2 (0.46) TDP1MEN1KMT2AHSD17B10MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE35279-E ALDOSE REDUCTASE INHIBITORS MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 1996-06-18 US disclosed
US-5202339-A Hypoglycemic, hypolipedemic agents MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 1993-04-13 US disclosed
EP-0305947-B1 HYDANTOIN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS WELL AS THEIR USE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 1992-07-29 EP disclosed
US-5004751-A Antidiabetic agents; aldoe reductase inhibitors MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 1991-04-02 US disclosed
US-4914099-A TREATMENT OR PREVENTION OF DIABETIC COMPLICATIONS MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 1990-04-03 US disclosed
WO-1989001934-A1 HYDANTOIN DERIVATIVES MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 1989-03-09 WO disclosed
EP-0305947-A1 Hydantoin derivatives, process for their preparation and pharmaceutical compositions containing the same as well as their use MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 1989-03-08 EP disclosed